Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Telehealth and Blowfish are GAME CHANGERS
View:
Post by Hiddensecrets on Feb 15, 2021 1:35pm

Telehealth and Blowfish are GAME CHANGERS

The recent news of MEDV to embark in the Telehealth and wellness market + the addition of Blowfish technology are game changers and, the stock will command a premium as stocks in this field trade at 30x earnings and, 10x sales because it is RECURRING income.

The covid19 testing cubes put us on the map but it will be telehealth and blowfish that carry us to the BILLION $$$ market cap. 

The biggest asset which MEDV is acquiring from the covid19 cubes is a LUCRATIVE PATIENT LIST to which it can begin to offer many other services.

What is fascinating from the telehealth market is that it represents RECURRING income.

Blowfish technolgy is a catch all technology in that all types of tests can be done, you are not limited to covid19.  Pfizer was interested for a reason. 

It goes without saying that covid19 with its many variants will continue to be with us for years and, testing by itself will not go away, the cost of having the virus resurface where it cripples economies and hospitals is simply too high.    Given that the WHO has already confirmed that he covid19 virus will become endemic meaing to be with us forever, testing will always be required until decades later it becomes like the common cold.

In the meantime, MEDV will rake in with covid19 as they expand their business towards the more lucrative and recurring telehealth and blowfish market.

Based on sales of say $ 50 million per year from telehealth alone, we would command a market cap of $ 1.5 billion, that would mean a stock price of $ 5 per share on this alone. 

PS:  I am following the results from Isreal very closely as they have close to 25% of the population vaccinated with Pfizer, double dose to date.   They are doing it properly.   And what is surprising is that the infection rate still remains pretty high and, deaths occurring on a daily basis, even though most of the vunerable crowd has been vaccinated.  So this begs the question, is the vaccine working????

MPO
Comment by CerealKiller on Feb 15, 2021 6:32pm
About Israel, more lies form the man who proved himself a liar by his own posting history: https://www.google.com/amp/s/www.bbc.co.uk/news/amp/health-56069460
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities